Star Health Insurance and Allied Insurance Company Limited has announced an analyst and institutional investor meeting scheduled for March 18, 2026 in Chennai. The company disclosed this information to stock exchanges in compliance with regulatory requirements under SEBI listing obligations.

Meeting Details

The scheduled meeting will involve discussions with institutional investors as part of the company's regular investor engagement activities. The meeting has been organized to provide updates and insights to the investment community.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has notified both BSE Limited and National Stock Exchange of India Limited about the scheduled meeting.

The company has made the presentation materials accessible through a dedicated link and also made the disclosure available on its official website at www.starhealth.in . The announcement includes a note that the meeting schedule may be subject to changes due to exigencies on the part of analysts, investors, or the company.

Documentation

The regulatory filing was signed by Jayashree Sethuraman, Company Secretary and Compliance Officer, on March 13, 2026. The document was digitally signed and submitted to the stock exchanges as part of the company's ongoing disclosure obligations to keep investors and stakeholders informed about material developments.

Star Health Insurance and Allied Insurance Company Limited has announced an analyst/institutional investor meeting scheduled for February 04, 2026 in Mumbai. The company informed both BSE and NSE about this regulatory disclosure under Regulation 30 through a formal communication dated February 03, 2026.

Meeting Details

The investor meeting is scheduled with specific timing and participant details as outlined by the company.

Regulatory Compliance

The company has fulfilled its disclosure obligations by notifying both major stock exchanges. Star Health trades on BSE with scrip code 543412 and on NSE under the symbol STARHEALTH. The communication was signed by Jayashree Sethuraman, Company Secretary & Compliance Officer, ensuring proper corporate governance protocols.

Short Notice Acknowledgment

Due to business exigencies on the part of the investors, the company scheduled this meeting at shorter notice than usual. Star Health has expressed regret for the abbreviated timeline and committed to ensuring timely intimation of future analyst and institutional investor meetings. This demonstrates the company's commitment to maintaining transparent communication practices with stakeholders.

Presentation Access

The company has provided access to meeting materials through a dedicated presentation link. Additionally, the disclosure will be made available on the company's official website at www.starhealth.in , ensuring broader accessibility for interested stakeholders and maintaining transparency standards required under regulatory guidelines.